Free Republic

Friday marked the worst day of the year for the stock market as the Dow plummeted by 748.63 points, and pharmaceutical companies like Pfizer and Moderna stocks saw a significant rise. The surges come amid reports from researchers at the Wuhan Institute of Virology identifying a potentially deadlier strain of coronavirus known as HKU5-CoV-2, which the media is now parroting. COVID-19 originated in a lab in Wuhan, which the media have told us for years was untrue. The research, published Tuesday in the scientific journal Cell, began to spark concerns, drawing eerie parallels to the early days of the COVID-19...

Former top pandemic health official Dr. Deborah Birx has made the startling admission that Covid mRNA “vaccines” were only developed as a desperate measure for vulnerable citizens and were never meant to be widely distributed among the population. Dr. Birx, who served as White House Coronavirus Response Coordinator in President Donald Trump’s first administration, also revealed that the injections were not “designed” to protect against COVID-19 infection. The former top health official made the confession during a recent appearance on Piers Morgan Uncensored. She stated that the mRNA injections were developed to target those at high risk of severe illness....

Moderna stock spiked in Wednesday trading, climbing 13.7% over the course of the day amid swelling concerns over the avian influenza outbreak in U.S. cattle...Moderna confirmed to Barron's that the company is in discussions with the federal government about "advancing our pandemic flu candidate." Pfizer did not immediately respond to a request for comment.

The U.S. National Institutes of Health (NIH) is refusing to release additional information about an agreement it reached over a COVID-19 vaccine that has earned it at least $400 million.The NIH declined to provide any materials in response to a Freedom of Information Act request from The Epoch Times.“The NIH withholds the entirety of the records as they are protected from release,” Gorka Garcia-Malene, an NIH officer, told The Epoch Times in a letter.She cited an exemption outlined in the act that allows government agencies to partially or fully withhold information.“In this case, exemption 3 incorporates 35 U.S.C. 209 (f),...

After the remarkable success of the mRNA vaccines in protecting people against COVID-19, scientists are turning their attention next to another annual respiratory scourge: influenza. Both Moderna and Pfizer—makers of the first vaccines to earn U.S. Food and Drug Administration (FDA) approval using the mRNA technology—are studying whether subbing in the influenza virus’ genetic material in that platform will prove equally fruitful. On Sept. 14, Pfizer announced that the first volunteers had received doses of its mRNA flu shot; the Phase 3 study will involve more than 25,000 adults in the U.S. ages 18 and up who will be randomly...